To the Editor: We write in response to Reid and colleagues’1 article on congenital cytomegalovirus (CMV). While many countries worldwide have established congenital CMV screening programs, Australia urgently needs to recognise the importance of targeted congenital CMV screening and tracking its outcomes.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Reid A, Bowen AC, Brennan‐Jones CG, Kuthubutheen. Congenital cytomegalovirus: the case for targeted infant screening in Australia. Med J Aust 2022; 216: 167‐171. https://www.mja.com.au/journal/2022/216/4/congenital‐cytomegalovirus‐case‐targeted‐infant‐screening‐australia
- 2. Webb E, Gillespie AN, Poulakis Z, et al. Feasibility and acceptability of targeted salivary cytomegalovirus screening through universal newborn hearing screening. J Paediatr Child Health 2022; 58: 288‐294.
- 3. National Health and Medical Research Council. Clinical trials and cohort studies grant applications recommended for funding commencing in 2021. https://protect‐au.mimecast.com/s/72dUCxnMJ5s1lOJ8kt85BWJ?domain=nhmrc.gov.au (viewed June 2022).
- 4. Cerebral Palsy Alliance. cCMV Register, 2018. https://cerebralpalsy.org.au/cmv/ccmv‐register/ (viewed June 2022).
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.